Column Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Column Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-210	Closed	-$15K	–	757
2020 Q4	$15K	Buy	+210	New	+$11K	﹤0.01%	414

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Column Capital Advisors's BEAT Position: Q1 2021 in Review

Column Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 210 shares — an estimated $15K sold.

Column Capital Advisors first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $15K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Column Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Column Capital Advisors sold 210 BioTelemetry, Inc. shares in Q1 2021, an estimated $15K.
Column Capital Advisors first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Column Capital Advisors's BioTelemetry, Inc. position peaked at $15K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Column Capital Advisors's 13F filing for Q1 2021, filed 10 May 2021.